High prevalence of ECG variations and abnormalities in young and healthy TaMoVac 01 HIV vaccine trial volunteers from Tanzania

por Mann, PJ, Munseri, P, Kaluwa, B, Missanga, M, Lwakatare, J, Hoelscher, M, Bakari, M, Janabi, M, Maboko, L, Sandström, E, Kroidl, A
Publicado 2012

Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime

por Bauer, A, Podola, L, Haule, A, Sudi, L, Nilsson, C, Mann, P, Missanga, M, Kaluwa, B, Maboko, L, Lueer, C, Mwakatima, M, Aboud, S, Bakari, M, Currier, J, Robb, M, Joseph, S, McCormack, S, Lyamuya, E, Wahren, B, Sandström, E, Biberfeld, G, Hoelscher, M, Kroidl, A, Geldmacher, C
Publicado 2012

Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen

por Podola, L, Bauer, A, Haule, A, Sudi, L, Nilsson, C, Godoy-Ramirez, K, Mann, P, Missanga, M, Kaluwa, B, Maboko, L, Lueer, C, Mwakatima, M, Aboud, S, Bakari, M, Currier, J, Robb, M, McCormack, S, Joseph, S, Lyamuya, E, Hoelscher, M, Wahren, B, Sandström, E, Biberfeld, G, Geldmacher, C, Kroidl, A
Publicado 2012